A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study
about
Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK PathwaysAdvances in the management of paediatric high-grade glioma.Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory NeuroblastomaMolecular profiling of childhood cancer: Biomarkers and novel therapiesAdvances in paediatric cancer treatmentThe histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines.The rationale for targeted therapies in medulloblastoma.Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.Medulloblastoma development: tumor biology informs treatment decisionsBiology and Treatment of Rhabdoid Tumor.Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma.Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastomaMedulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update.Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification.Retrospective evaluation of the outcomes of children with diffuse intrinsic pontine glioma treated with radiochemotherapy and valproic acid in a single center.Histone deacetylase inhibitor for NUT midline carcinoma.Characterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors.Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule
P2860
Q28550980-8CAF8FCA-DAC3-4BF9-A465-D97C07035D32Q30870633-184C50D7-9B7C-49C1-94F8-23EE552AA06BQ33420546-86A3163D-BCB5-4A4C-B6AF-048AF52EF67EQ36250783-1D56C5D5-8D5B-45ED-BED8-C0C4D1543FCDQ36508630-74530553-B09F-4A5F-ABE1-C3B5B0507B81Q36810416-A8D99B6C-D250-47D3-8337-674C2CB9EDDCQ37409736-FBE36B35-127C-463E-8AFD-AC9C32F73CBDQ38139309-A722C6BC-EBDE-4D9C-B356-1C8CF94D7766Q38376606-BCD06EF8-4476-4F56-B5E6-EB03EFDD60BBQ38582867-6F01EDA7-E339-4743-AB7D-511B6E2794A3Q39236500-B11B7639-1D3D-4192-BBFB-D3EAAFF3C9F7Q41728555-568F2941-F97C-420A-83E1-8E9A0669AC4DQ47133403-BA6470E0-8A1C-47CE-A140-A1BBD59DC37FQ47282920-CD0ED027-13C1-42FE-A797-43A8F617A6ADQ47843990-CFA7D374-2FCA-4E19-B5B0-C2C38E32D60BQ48831107-ADE7B0BA-B737-4DA5-B89C-AC16A1C6E194Q51065495-E7EB6CDC-21BA-4FFF-B462-98873365950BQ52724801-9A255AC9-12A0-47A7-BF01-4E7C4B0633F0Q57299883-11BCA649-9C55-46F9-8F66-6E85EAD74FF2
P2860
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A pediatric phase 1 trial of v ...... Group phase 1 consortium study
@ast
A pediatric phase 1 trial of v ...... Group phase 1 consortium study
@en
type
label
A pediatric phase 1 trial of v ...... Group phase 1 consortium study
@ast
A pediatric phase 1 trial of v ...... Group phase 1 consortium study
@en
prefLabel
A pediatric phase 1 trial of v ...... Group phase 1 consortium study
@ast
A pediatric phase 1 trial of v ...... Group phase 1 consortium study
@en
P2093
P2860
P356
P1476
A pediatric phase 1 trial of v ...... Group phase 1 consortium study
@en
P2093
Ashish M Ingle
Brenda Weigel
Charlotte Ahern
Joel M Reid
Lars Wagner
Matthew M Ames
Renee M McGovern
Richard J Gilbertson
Terzah Horton
Trent R Hummel
P2860
P304
P356
10.1002/PBC.24541
P577
2013-03-28T00:00:00Z